Regulation of cardiovascular development and integrity by the heart of glass–cerebral cavernous malformation protein pathway-Reference-Cited by-同舟云学术

Regulation of cardiovascular development and integrity by the heart of glass–cerebral cavernous malformation protein pathway

Published:2009-01-18 Issue:2 Volume:15 Page:169-176
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Kleaveland Benjamin,Zheng Xiangjian,Liu Jian J,Blum Yannick,Tung Jennifer J,Zou Zhiying,Sweeney Shawn M,Chen Mei,Guo Lili,Lu Min-min,Zhou Diane,Kitajewski Jan,Affolter Markus,Ginsberg Mark H,Kahn Mark L

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.1918.pdf

Reference31 articles.

1. Rigamonti, D. et al. Cerebral cavernous malformations. Incidence and familial occurrence. N. Engl. J. Med. 319, 343–347 (1988).

2. Revencu, N. & Vikkula, M. Cerebral cavernous malformation: new molecular and clinical insights. J. Med. Genet. 43, 716–721 (2006).

3. Sahoo, T. et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum. Mol. Genet. 8, 2325–2333 (1999).

4. Eerola, I. et al. KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum. Mol. Genet. 9, 1351–1355 (2000).

5. Liquori, C.L. et al. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am. J. Hum. Genet. 73, 1459–1464 (2003).

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oscillatory contractile forces refine endothelial cell-cell interactions for continuous lumen formation governed by Heg1/Ccm1;Angiogenesis;2024-09-09

2. A renaissance of cerebral cavernous malformation proteins in vascular physiology;Nature Cardiovascular Research;2024-06-27

3. Diagnostic performance of immunohistochemistry markers for malignant pleural mesothelioma diagnosis and subtypes. A systematic review and meta-analysis;Pathology - Research and Practice;2024-05

4. Clinical pharmacology and tolerability of REC‐994, a redox‐cycling nitroxide compound, in randomized phase 1 dose‐finding studies;Pharmacology Research & Perspectives;2024-04-24

5. Hemodynamic Forces and Atherosclerosis: HEG1 at the Center of the Jigsaw Puzzle;Circulation;2024-04-09